SLC25A20 and neoplasm: Recently, a mass spectrometry (MS)-based proteomics study in a large cohort of tumor tissues from 159 HBV-related HCC patients has identified SLC25A20 as one of the robust and representative prognostic proteins in HCC10, implying that SLC25A20 may play important roles in the development and progression of HCC.